RATIOS
Marksans Pharma Ltd.
BSE
Jun 06
252.10
-5.75 ( -2.23%)
Volume
164385
Prev. Close
257.85
Open Price
256.75
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 06
251.95
-5.90 ( -2.29%)
Volume
1156438
Prev. Close
257.85
Open Price
257.85
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
ISIN No
|
INE750C01026
|
Market Cap. ( ₹ in Cr. )
|
11417.46
|
P/BV
|
5.00
|
Book Value ( ₹ )
|
50.34
|
BSE Code
|
524404
|
52 Week High/Low ( ₹ )
|
359/148
|
FV/ML
|
1/1
|
P/E(X)
|
30.00
|
NSE Code
|
MARKSANSEQ
|
Book Closure
|
17/09/2024
|
EPS ( ₹ )
|
8.40
|
Div Yield (%)
|
0.32
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 4.15 | 2.95 | 2.48 | 2.54 | 2.40 |
Diluted EPS (Rs.) | 4.15 | 2.95 | 2.48 | 2.54 | 2.40 |
Cash EPS (Rs.) | 4.80 | 3.59 | 2.64 | 2.97 | 2.77 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 30.53 | 26.98 | 24.52 | 19.17 | 14.65 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 30.53 | 26.98 | 24.52 | 19.17 | 14.65 |
Dividend / Share (Rs.) | 0.80 | 0.60 | 0.50 | 0.25 | 0.25 |
Revenue From Operations / Share (Rs.) | 25.92 | 18.83 | 14.46 | 16.08 | 14.65 |
PBDIT / Share (Rs.) | 6.04 | 4.46 | 3.36 | 3.81 | 3.54 |
PBIT / Share (Rs.) | 5.39 | 3.81 | 2.99 | 3.38 | 3.17 |
PBT / Share (Rs.) | 5.37 | 3.79 | 2.91 | 3.29 | 3.04 |
Net Profit / Share (Rs.) | 4.15 | 2.95 | 2.27 | 2.54 | 2.40 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 23.32 | 23.67 | 23.25 | 23.69 | 24.16 |
PBIT Margin (%) | 20.81 | 20.26 | 20.70 | 21.00 | 21.62 |
PBT Margin (%) | 20.71 | 20.14 | 20.15 | 20.43 | 20.73 |
Net Profit Margin (%) | 16.03 | 15.67 | 15.69 | 15.79 | 16.40 |
Return on Networth / Equity (%) | 13.60 | 10.93 | 9.25 | 13.25 | 16.40 |
Return on Capital Employeed (%) | 17.33 | 13.90 | 12.02 | 17.30 | 20.79 |
Return On Assets (%) | 10.72 | 8.82 | 7.64 | 10.76 | 13.69 |
Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Asset Turnover Ratio (%) | 0.71 | 0.59 | 0.56 | 0.78 | 0.90 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 3.13 | 3.48 | 4.22 | 3.54 | 3.68 |
Quick Ratio (X) | 2.54 | 2.78 | 3.62 | 2.92 | 2.69 |
Inventory Turnover Ratio (X) | 2.71 | 2.53 | 2.89 | 3.32 | 3.46 |
Dividend Payout Ratio (NP) (%) | 0.00 | 16.93 | 9.88 | 9.84 | 4.16 |
Dividend Payout Ratio (CP) (%) | 0.00 | 13.91 | 8.50 | 8.41 | 3.60 |
Earning Retention Ratio (%) | 0.00 | 83.07 | 90.12 | 90.16 | 95.84 |
Cash Earning Retention Ratio (%) | 0.00 | 86.09 | 91.50 | 91.59 | 96.40 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 233.29 | 204.46 | 42.18 | 41.10 | 27.10 |
Interest Coverage Ratio (Post Tax) (%) | 161.37 | 136.38 | 29.47 | 28.40 | 19.41 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 9807.32 | 6555.41 | 2754.06 | 1645.36 | 1938.81 |
EV / Net Operating Revenue (X) | 8.35 | 7.68 | 4.20 | 2.50 | 3.23 |
EV / EBITDA (X) | 35.81 | 32.45 | 18.07 | 10.55 | 13.38 |
MarketCap / Net Operating Revenue (X) | 8.58 | 8.05 | 4.88 | 2.83 | 3.41 |
Retention Ratios (%) | 0.00 | 83.06 | 90.11 | 90.15 | 95.83 |
Price / BV (X) | 7.28 | 5.62 | 2.87 | 2.38 | 3.41 |
Price / Net Operating Revenue (X) | 8.58 | 8.05 | 4.88 | 2.83 | 3.41 |
EarningsYield | 0.01 | 0.01 | 0.03 | 0.05 | 0.04 |